Carregando...
Adjunct ketamine treatment of depression in treatment‐resistant schizophrenia patients is unsatisfactory in pilot and secondary follow‐up studies
OBJECTIVE: To investigate the effects of adjunct ketamine treatment on chronic treatment‐resistant schizophrenia patients with treatment‐resistant depressive symptoms (CTRS‐TRD patients), including alterations in brain function. METHODS: Intravenous ketamine (0.5 mg/kg body weight) was administered...
Na minha lista:
| Publicado no: | Brain Behav |
|---|---|
| Principais autores: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7218248/ https://ncbi.nlm.nih.gov/pubmed/32174025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1600 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|